Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 48 min ago
Peer-reviewedCC BY 4.0JAMA Network Open

Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence

  1. 1Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City
  2. 2Center for Access & Delivery Research and Evaluation (CADRE), Iowa City VA Health Care System, Iowa City, Iowa

Related

  1. Effectiveness and safety of cefazolin vs antistaphylococcal penicillins for methicillin-susceptible Staphylococcus aureus bacteremia: a multicenter real-world evaluation using the international TriNetX database
    Natesan Ramsamy, Maïa Simon, Isabelle Adam +6
    Antimicrobial Agents and ChemotherapyPeer-reviewedCC BY-NC-SA 4.0Full textGeneral biologyInfectious diseaseHAL
  2. Cefazolin versus Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    F. Pozzebon, G. Pacheco, G. Cabral +3
    medRxivPreprintCC BY-NC-NDFull textInfectious diseasemedRxiv
  3. Chlorhexidine MIC distribution, efflux pump gene profiles, and genotypic characteristics among clinical methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates
    Mina Golban, Javad Charostad, Hossein Kazemian +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textInfectious diseaseCrossref
  4. Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia
    The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group
    New England Journal of MedicinePeer-reviewedLicence not stated24 citedInfectious diseaseOpenAlex
  5. Routine Serial Follow-up Blood Cultures After a Negative Result Within 48 Hours of Methicillin-susceptible Staphylococcus aureus Bacteremia: Low Yield, High Cost
    Marianne M C Hendriks, Eline H H M Kamps, Cairo Norberhuis +6
    Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of AmericaPeer-reviewedCC BY 4.0Full text1 citedInfectious diseasePMC
BibTeX
@article{goto2026cefazolin,
  title = {{Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence}},
  author = {Michihiko Goto},
  journal = {JAMA Network Open},
  year = {2026},
  month = nov,
  doi = {10.1001/jamanetworkopen.2026.43842},
  url = {https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2856579},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence
AU  - Michihiko Goto
PY  - 2026
DA  - 2026/11/12
JO  - JAMA Network Open
DO  - 10.1001/jamanetworkopen.2026.43842
UR  - https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2856579
SN  - 2574-3805
ER  -